PainChek Limited (ASX:PCK)

Australia · Delayed Price · Currency is AUD

0.0900

+0.0020 (2.27%)

Oct 20, 2026, 4:10 PM AEST

Market Cap	18.81M -84.7%
Revenue (ttm)	3.74M +11.3%
Net Income	-8.94M
EPS	-0.04
Shares Out	209.01M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	32,222
Open	0.0900
Previous Close	0.0880
Day's Range	0.0900 - 0.0900
52-Week Range	0.0860 - 0.6000
Beta	0.47
Analysts	n/a
Price Target	n/a
Est. Earnings	Oct 29, 2026

About PainChek

PainChek Limited engages in the development and commercialization of mobile medical device applications that provides pain assessment for individuals in Australia, the United Kingdom, and internationally. The company provides PainChek, a clinically validated medical device that uses smartphone cameras for a facial scan then is analyzed using facial recognition AI technology to identify the presence of pain. It serves individuals that are unable to communicate with their carers. The company was formerly known as ePAT Technologies Ltd and changed... [Read more]

Industry Health Information Services

Sector Healthcare

CEO Karen Holzberger

Country Australia

Stock Exchange Australian Securities Exchange

Ticker Symbol PCK

Full Company Profile

Financial Performance

In fiscal year 2026, PainChek's revenue was 3.74 million, an increase of 11.29% compared to the previous year's 3.36 million. Losses were -8.94 million, 16.5% more than in 2025.

Financial Statements